Skip to main content
Daniel Pelletier, MD, Neurology, Los Angeles, CA

DanielPelletierMD

Neurology Los Angeles, CA

Associate Professor, Neurology, Yale University School of Medicine

Are you Dr. Pelletier?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 48 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    1520 San Pablo St
    Suite 3000
    Los Angeles, CA 90033
    Phone+1 323-442-5710
    Fax+1 203-737-6375

Summary

  • Dr. Daniel Pelletier, MD is a neurologist in Los Angeles, California. He is currently licensed to practice medicine in California, Michigan, and Connecticut. He is affiliated with Keck Hospital of USC and USC Norris Comprehensive Cancer Center.

Education & Training

  • Laval Univ
    Laval UnivClass of 1994

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2023 - 2026
  • CA State Medical License
    CA State Medical License 1999 - 2024
  • CT State Medical License
    CT State Medical License 2011 - 2015

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • MS Treatment Extends Time to First Symptom in Trial in People with Radiologically Isolated Syndrome (RIS)
    MS Treatment Extends Time to First Symptom in Trial in People with Radiologically Isolated Syndrome (RIS)December 15th, 2022
  • Repopulation of T, B, and NK Cells Following Alemtuzumab Treatment in Relapsing-Remitting Multiple Sclerosis
    Repopulation of T, B, and NK Cells Following Alemtuzumab Treatment in Relapsing-Remitting Multiple SclerosisJune 15th, 2020
  • Phase 2 Trial Testing NurOwn Therapy for Progressive MS Adds Third Clinical Site
    Phase 2 Trial Testing NurOwn Therapy for Progressive MS Adds Third Clinical SiteJuly 12th, 2019
  • Join now to see all

Other Languages

  • French